BioNexus Gene Lab Corp. Other Noncash Income
BioNexus Gene Lab Corp. (BGLC) reported Other Noncash Income of $8.95 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncome · last filed 2024-05-15
- BioNexus Gene Lab Corp. other noncash income for the quarter ending 2024-03-31 was $8.95K, a 2.92% increase year-over-year.
- BioNexus Gene Lab Corp. other noncash income for the quarter ending 2023-03-31 was $8.69K.
| Period end | Other Noncash Income 3 month |
|---|---|
| 2024-03-31 | $8.95K 10-Q · filed 2024-05-15 |
| 2023-03-31 | $8.69K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |